Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

✍ Scribed by Sucheta Telang; Mary Ann Rasku; Amy L Clem; Karen Carter; Alden C Klarer; Wesley R Badger; Rebecca A Milam; Shesh N Rai; Jianmin Pan; Hana Gragg; Brian F Clem; Kelly M McMasters; Donald M Miller; Jason Chesney

• Book ID: 115010397
• Publisher: BioMed Central
• Year: 2011
• Tongue: English
• Weight: 342 KB
• Volume: 11
• Category: Article
• ISSN: 1471-2407
• DOI: 10.1186/1471-2407-11-515